BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 11, 2020
View Archived Issues
'Gut bug' has intratumoral effects
Read More
Decoy exosomes fight bacterial toxin
Read More
AbbVie begins first-in-human study of ABBV-184 in previously treated AML and NSCLC
Read More
NCI selects Curadigm's Nanoprimer technology for characterization
Read More
Mesoblast to evaluate remestemcel-L for treatment of COVID-19 lung disease
Read More
Brilacidin to be tested against COVID-19
Read More
FDA clears IND applications for phase I study of CAD-9303 in schizophrenia
Read More
Nuclear NR4A3 expression as novel diagnostic biomarker of ACC-SG
Read More
SATB2 as novel biomarker of neuroendocrine differentiation in gynecological tumors
Read More
Broadly neutralizing antibody plus latency reversing treatment evaluated in HIV trial
Read More
Novel 18F-labeled tryptophan analogue as a PET imaging probe for Shh medulloblastoma
Read More
GEMoaB initiates first-in-human study of UniCAR-T-CD123 in acute leukemias
Read More
Chinese researchers patent JAK inhibitors
Read More
Rudong Ringene Pharmaceuticals divulges FGFR inhibitors
Read More
AZD-2373 begins first-in-human trial in healthy male subjects of African ancestry
Read More
KeyBioscience discloses new compounds for diabetes
Read More
Beijing Yuezhikangtai Biomedicines presents new tyrosine kinase inhibitors
Read More
Beijing Scitech-Mq Pharmaceuticals identifies VEGFR-2 and CSF-1R inhibitors
Read More
Researchers debut open-source platform for in silico small molecule screening
Read More
Neoantigen-rich murine melanoma cell model devised to study checkpoint inhibitor responses
Read More
First phase I study of cannabinol cream INM-755 completes enrollment
Read More
Gilead presents 96-week data from DISCOVER trial of Descovy for PrEP
Read More
Tiziana accelerates development of TZLS-501 for COVID-19
Read More
Novo Nordisk initiates phase I study of NNC0472-0147 for type 2 diabetes
Read More
Nucana reports preliminary data from phase II study of Acelarin in ovarian cancer
Read More